The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region

作者: M.-M. Georgescu , K. H. Kirsch , T. Akagi , T. Shishido , H. Hanafusa

DOI: 10.1073/PNAS.96.18.10182

关键词:

摘要: PTEN is a recently identified tumor suppressor inactivated in variety of cancers such as glioblastoma and endometrial prostate carcinoma. It contains an amino-terminal phosphatase domain acts phosphatidylinositol 3,4,5-trisphosphate antagonizing the activity 3-OH kinase. also carboxyl-terminal domain, we addressed role this region that, analogous to target many mutations tumors. Expression mutants PTEN-deficient cells permitted anchorage-independent growth that otherwise was suppressed by wild-type PTEN. The stability these reduced because rapid degradation. Although regulatory PEST sequences PDZ-binding motif, specific elements were dispensable for tumor-suppressor function. study point affecting revealed located strongly predicted β-strands. Surprisingly, affected correlation with degree disruption structural elements. We conclude essential regulating enzymatic are responsible reversion phenotype. propose molecular conformational changes induced constitute mechanism inactivation.

参考文章(37)
Georgia Chenevix-Trench, Andrew Hitchcock, Eric J. Thomas, Sarah J. Morland, Ian G. Campbell, Richard H. Watson, Koshiro Obata, Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Research. ,vol. 58, pp. 2095- 2097 ,(1998)
Marian S. Blazes, Kathleen R. Cho, Steven I. Wang, Ramon Parsons, Shikha Bose, Lora Hedrick Ellenson, Hironori Tashiro, Jing Li, Rong Wu, Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Research. ,vol. 57, pp. 3935- 3940 ,(1997)
Andrew Berchuck, John I. Risinger, J. Carl Barrett, A. Kate Hayes, PTEN/MMAC1 Mutations in Endometrial Cancers Cancer Research. ,vol. 57, pp. 4736- 4738 ,(1997)
Andrew Berchuck, John I. Risinger, P. Andrew Futreal, Rex C. Bentley, G. Larry Maxwell, J. Carl Barrett, Heather Shaw, Curtis Gumbs, Mutation of the PTEN Tumor Suppressor Gene in Endometrial Hyperplasias Cancer Research. ,vol. 58, pp. 2500- 2503 ,(1998)
Guido Reifenberger, Ghazaleh Tabatabai, Marietta Wolter, J. M. J. Ludwig Cobbers, V. Peter Collins, Peter Lichter, Ruthild G. Weber, Jan Boström, Mutation of the PTEN (MMAC1) Tumor Suppressor Gene in a Subset of Glioblastomas but not in Meningiomas with Loss of Chromosome Arm 10q Cancer Research. ,vol. 58, pp. 29- 33 ,(1998)
Faina Bogomolniy, Esther Rhei, Patrick I. Borgen, Lan Kang, Mark G. Federici, Jeff Boyd, Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Primary Breast Carcinomas Cancer Research. ,vol. 57, pp. 3657- 3659 ,(1997)
J Avanzini, S V Tavtigian, K N Wills, I W Cheney, P W Shabram, G W Demers, A Morimoto, R Bookstein, M T Vaillancourt, J B Bolen, D E Johnson, Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Research. ,vol. 58, pp. 2331- 2334 ,(1998)
A Charest, J Wagner, S H Shen, M L Tremblay, Murine protein tyrosine phosphatase-PEST, a stable cytosolic protein tyrosine phosphatase Biochemical Journal. ,vol. 308, pp. 425- 432 ,(1995) , 10.1042/BJ3080425
E Flores, G Roy, D Patel, A Shaw, M L Thomas, Nuclear localization of the PEP protein tyrosine phosphatase. Molecular and Cellular Biology. ,vol. 14, pp. 4938- 4946 ,(1994) , 10.1128/MCB.14.7.4938
Paul Cairns, David Sidransky, Janusz Puc, Jeffrey N. Bruce, Steven I. Wang, Ramon Parsons, Jing Li, Somatic mutations of PTEN in glioblastoma multiforme. Cancer Research. ,vol. 57, pp. 4183- 4186 ,(1997)